Tehrani v. Hamilton Technologies: Federal Circuit Affirms Ventilator Patent Ruling
Fleur Tehrani appealed a patentability determination involving US7802571B2, covering a method and apparatus for controlling a ventilator, against Hamilton Technologies, LLC. The Federal Circuit affirmed the decision below in a case that ran 426 days from filing to close.
Federal Circuit affirms ventilator patent patentability ruling
Fleur Tehrani, represented by Kendrick Intellectual Property Law, brought this appeal before the United States Court of Appeals for the Federal Circuit on 28 April 2022. The appeal concerned the patentability of US7802571B2, a patent covering a method and apparatus for controlling a ventilator, asserted against Hamilton Technologies, LLC. The case falls under invalidity and cancellation proceedings, placing the patent's survival squarely at issue.
The Federal Circuit issued its disposition on 28 June 2023, ordering: 'THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: AFFIRMED.' The recorded Basis of Termination is 'Appeal Dismissed'; the docket order is styled as an affirmance. The specific terms and reasoning underlying the court's disposition are not further disclosed in the available record.
The 426-day duration is consistent with standard Federal Circuit appellate timelines for patentability matters. What drove the affirmance — whether procedural or on the merits of the invalidity arguments — is not elaborated in the available record, and no further public findings are disclosed.
See Complete Case & Patent Analysis →Filing to Appeal Dismissed in 426 days
426 days from filing to Federal Circuit disposition — a typical appellate timeline for a patentability appeal
US7802571B2 — Method and apparatus for controlling a ventilator
Any company designing, manufacturing, or commercialising ventilator control systems — including standalone ventilators, transport ventilators, or integrated respiratory management platforms — should consider a freedom-to-operate analysis against US7802571B2. The Federal Circuit affirmance means the patent's status has survived appellate challenge, increasing the risk profile for third parties whose products may fall within the patent's claim scope. This is particularly relevant for device makers entering or expanding in the mechanical ventilation segment.
Official order — verbatim text
The Federal Circuit's order — 'ORDERED AND ADJUDGED: AFFIRMED' — indicates the court found no reversible error in the tribunal's determination below on the patentability of US7802571B2. The recorded Basis of Termination is 'Appeal Dismissed'; the docket order is styled as an affirmance. The standard of review applied and the specific grounds on which the affirmance rests are not elaborated in the available public record.
Federal Circuit affirms: what the ruling means for both parties
What 'AFFIRMED' means at the Federal Circuit
An affirmance by the Federal Circuit means the court found no reversible error in the decision rendered below. The lower tribunal's findings and legal conclusions are upheld. The appellant — Fleur Tehrani — has exhausted appellate review at this level. The decision below, including any adverse patentability determination, now stands as the operative ruling on US7802571B2.
No reversible error foundTehrani's patent faces an upheld adverse ruling
As appellant, Tehrani sought to overturn the patentability determination below. The Federal Circuit's affirmance means that challenge failed at this level. The enforceability and validity status of US7802571B2 continues to be governed by the affirmed lower decision. Further appellate options — such as petition for certiorari to the Supreme Court — remain theoretically available but represent a substantially higher bar.
Appeal unsuccessful for patent holderHamilton Technologies prevails on appeal
Hamilton Technologies, LLC, as appellee, benefits from the Federal Circuit's affirmance. The invalidity or cancellation arguments that formed the basis of the proceedings below have been sustained through this appellate review. The risk of the lower decision being reopened at this level is eliminated. Any future challenge to the patent's validity would face the heightened burden of overcoming an affirmed determination.
Appellee prevails; lower ruling standsVentilator control patent landscape: affirmance raises the bar
For the ventilator and respiratory device sector, a Federal Circuit affirmance of a patentability determination signals that the specific claims of US7802571B2 have survived appellate scrutiny — or that challenges to them were upheld — depending on which party prevailed below. Competitors and R&D teams working on ventilator control methods should assess the claim scope of US7802571B2 in any freedom-to-operate analysis, as the affirmed status increases the precedential weight of the underlying ruling.
Strengthened precedential postureFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Fleur Tehrani | Individual | /Search in Eureka ↗ |
| Defendant | Hamilton Technologies, LLC | Company | /Search in Eureka ↗ |
| Plaintiff counsel | Mark Robert Kendrick | Attorney | Counsel for Fleur TehraniSearch in Eureka ↗ |
| Plaintiff law firm | Kendrick Intellectual Property Law | Law Firm | Representing Fleur TehraniSearch in Eureka ↗ |
| Defendant counsel | Matthew L. Fedowitz | Attorney | Counsel for Hamilton Technologies, LLCSearch in Eureka ↗ |
| Defendant counsel | Patrick C. Keane | Attorney | Counsel for Hamilton Technologies, LLCSearch in Eureka ↗ |
| Defendant counsel | Ralph George Fischer | Attorney | Counsel for Hamilton Technologies, LLCSearch in Eureka ↗ |
| Defendant law firm | Buchanan, Ingersoll & Rooney PC | Law Firm | Representing Hamilton Technologies, LLCSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
R&D signals in the ventilator control patent space
Forward-looking patent and innovation intelligence derived from the Tehrani v. Hamilton Technologies dispute — tracking filing trends, white space, and competitive posture in ventilator control technology.
Tehrani's ventilator patent family: continuation and related filings
Individual inventors in the medical device space frequently file continuation, divisional, or continuation-in-part applications around a core disclosure. Analysing the patent family stemming from application US10/935446 can reveal whether additional claims related to ventilator control methods remain active or are pending — representing ongoing IP risk or licensing opportunity for the sector.
Portfolio & continuation riskFiling trends: ventilator control method patents post-2020
The ventilator sector saw a surge in patent filings following the COVID-19 pandemic, with increased activity in control algorithms, adaptive pressure management, and AI-driven respiratory monitoring. Understanding the density of filings around ventilator control methods helps R&D teams identify crowded claim spaces and emerging white space for differentiated innovation.
Sector filing trendsHamilton Technologies' patent activity in respiratory devices
Hamilton Technologies' successful defence in this Federal Circuit appeal suggests active IP engagement in the ventilator space. Mapping Hamilton Technologies' own patent filings and prosecution history can reveal their offensive and defensive IP strategy — intelligence relevant for competitors, potential licensees, and R&D teams assessing the ventilator control competitive landscape.
Competitor IP mappingAdjacent innovation gaps in ventilator control architectures
Despite dense filings in core ventilator control methods, adjacent spaces — such as AI-driven weaning protocols, closed-loop pressure support, and paediatric ventilation algorithms — may present white-space filing opportunities. A patent landscape analysis around US7802571B2's claim scope can surface these gaps for R&D teams looking to build defensible IP in the respiratory device sector.
White space & filing gapsSimilar Federal Circuit appeals in ventilator and medical device patents
Explore comparable patentability appeals at the Federal Circuit involving medical device control method patents, including ventilator and respiratory therapy claims.
What this case signals for the ventilator IP landscape
A Federal Circuit affirmance in a ventilator control patentability dispute has direct implications for patent holders and challengers in the respiratory device space.
Affirmed patentability rulings raise the cost of further challenge
With the Federal Circuit affirming the decision below, any party seeking to relitigate the validity of US7802571B2 faces a significantly higher evidentiary and procedural burden. IP teams monitoring this patent should update their freedom-to-operate assessments to reflect the affirmed status and the reduced likelihood of successful re-challenge at this stage.
Ventilator control methods remain a contested patent domain
The fact that this dispute reached the Federal Circuit on patentability grounds suggests that claim scope and validity of ventilator control method patents are actively contested. R&D and legal teams in the respiratory device sector should track the claim boundaries of US7802571B2 and monitor related filings for design-around opportunities or exposure risk.
Tehrani v Hamilton — key questions answered
The Federal Circuit issued an order affirming the decision below in case No. 22-1732. The order states: 'THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: AFFIRMED.' The recorded Basis of Termination is 'Appeal Dismissed.' The case closed on 28 June 2023, approximately 426 days after filing.
The patent at issue is US7802571B2, filed under application number US10/935446. It covers a method and apparatus for controlling a ventilator. The dispute arose as an invalidity and cancellation action, with patentability as the central verdict cause.
The affirmance means the Federal Circuit found no reversible error in the tribunal's determination below regarding the patentability of US7802571B2. The underlying ruling now stands. The specific grounds for the affirmance and the detailed reasoning are not elaborated in the available public record.
The appeal was heard by the United States Court of Appeals for the Federal Circuit, District of Columbia region. The case number is 22-1732. The case was filed on 28 April 2022 and closed on 28 June 2023.
For ventilator manufacturers and medical device developers, the affirmance increases the precedential weight of the underlying patentability ruling on US7802571B2. Companies whose products involve ventilator control methods should assess whether their implementations intersect with the patent's claims and consider a freedom-to-operate analysis, given the affirmed appellate status and reduced likelihood of successful re-challenge at this level.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.